(Q39632788)

English

Safety and efficacy profile of bioresorbable-polylactide-polymer-biolimus-A9-eluting stents versus durable-polymer-everolimus- and zotarolimus-eluting stents in patients with acute coronary syndrome

scientific article published on 5 July 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Safety and efficacy profile of bioresorbable-polylactide-polymer-biolimus-A9-eluting stents versus durable-polymer-everolimus- and zotarolimus-eluting stents in patients with acute coronary syndrome (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Thomas Lüscher

12

object named as

Thomas F Lüscher

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Milosz Jaguszewski

1

object named as

Milosz Jaguszewski

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

author name string

Manuela Dörig

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Antonio H Frangieh

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Jelena-Rima Ghadri

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Victoria Lucia Cammann

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Johanna Diekmann

6

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

L Christian Napp

7

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Fabrizio D'Ascenzo

8

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Yoichi Imori

9

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Slayman Obeid

10

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Willibald Maier

11

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Christian Templin

13

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

publication date

5 July 2016

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Catheterization and Cardiovascular Interventions

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

88

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

E173-E182

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCCD.26617

21 January 2018

Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry

1 reference

https://api.crossref.org/works/10.1002%2FCCD.26617

21 January 2018

Drug-eluting coronary-artery stents.

1 reference

https://api.crossref.org/works/10.1002%2FCCD.26617

21 January 2018

Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCCD.26617

21 January 2018

Comparison of biolimus A9-eluting (Nobori) and everolimus-eluting (Promus Element) stents in patients with de novo native long coronary artery lesions: a randomized Long Drug-Eluting Stent V trial

1 reference

https://api.crossref.org/works/10.1002%2FCCD.26617

21 January 2018

Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: a randomized, controlled, noninferiority trial

1 reference

https://api.crossref.org/works/10.1002%2FCCD.26617

21 January 2018

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial

1 reference

https://api.crossref.org/works/10.1002%2FCCD.26617

21 January 2018

Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCCD.26617

21 January 2018

Clinical end points in coronary stent trials: a case for standardized definitions

1 reference

https://api.crossref.org/works/10.1002%2FCCD.26617

21 January 2018

Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study

1 reference

https://api.crossref.org/works/10.1002%2FCCD.26617

21 January 2018

Favorable vessel healing after nobori biolimus A9-eluting stent implantation-6- and 12-month follow-up by optical coherence tomography

1 reference

https://api.crossref.org/works/10.1002%2FCCD.26617

21 January 2018

Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial.

1 reference

https://api.crossref.org/works/10.1002%2FCCD.26617

21 January 2018

Vascular response to drug-eluting stent with biodegradable vs. durable polymer. Optical coherence tomography substudy of the NEXT.

1 reference

https://api.crossref.org/works/10.1002%2FCCD.26617

21 January 2018

Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCCD.26617

21 January 2018

Impact of drug-eluting stents with different coating strategies on stent thrombosis: A meta-analysis of 19 randomized trials.

1 reference

https://api.crossref.org/works/10.1002%2FCCD.26617

21 January 2018

Long time clinical outcomes of limus-eluting stent versus paclitaxel-eluting stent in patients undergoing percutaneous coronary artery intervention: A meta-analysis of randomized controlled clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCCD.26617

21 January 2018

Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

1 reference

https://api.crossref.org/works/10.1002%2FCCD.26617

21 January 2018

Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: a systematic review and Bayesian approach network meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCCD.26617

21 January 2018

Different patterns of neointimal coverage between acute coronary syndrome and stable angina after various types of drug-eluting stents implantation; 9-month follow-up optical coherence tomography study.

1 reference

https://api.crossref.org/works/10.1002%2FCCD.26617

21 January 2018

Frequency, predictors, and outcomes of drug-eluting stent utilization in patients with high-risk non-ST-segment elevation acute coronary syndromes.

1 reference

https://api.crossref.org/works/10.1002%2FCCD.26617

21 January 2018

Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization

1 reference

https://api.crossref.org/works/10.1002%2FCCD.26617

21 January 2018

Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study

1 reference

https://api.crossref.org/works/10.1002%2FCCD.26617

21 January 2018

Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCCD.26617

21 January 2018

Biolimus-eluting stents with biodegradable polymer versus bare-metal stents in acute myocardial infarction: two-year clinical results of the COMFORTABLE AMI trial

1 reference

https://api.crossref.org/works/10.1002%2FCCD.26617

21 January 2018

Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis.

1 reference

https://api.crossref.org/works/10.1002%2FCCD.26617

21 January 2018

Meta-analysis of bioabsorbable versus durable polymer drug-eluting stents in 20,005 patients with coronary artery disease: an update.

1 reference

https://api.crossref.org/works/10.1002%2FCCD.26617

21 January 2018

Efficacy and safety of biodegradable polymer biolimus-eluting stents versus durable polymer drug-eluting stents: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCCD.26617

21 January 2018

One-year outcome from an all-comers population of patients with ST-segment elevation myocardial infarction treated with biolimus-eluting stent with biodegradable polymer.

1 reference

https://api.crossref.org/works/10.1002%2FCCD.26617

21 January 2018

Identifiers

10.1002/CCD.26617

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39632788&oldid=1848635533"